Thanks gmfj. Theres been a lot of bluster on here without anyone actually answering my original quesions.
how will msb get the 1000s of donors theyll need for all there products if 1 donor=500-100 doses and how will they show all donors produce the same product without doing a new clincal trial for all of them(clinical equivalence))
i'm not trying to tear down msb in fact i want it to succeed for the sake of all aussie biotechs. seems a legit question to me though, and macbank and others thik so too.
long bone fracture, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |